These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers. Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569 [TBL] [Abstract][Full Text] [Related]
6. On the importance of accurate quantification of individual volatile metabolites in exhaled breath. Smith D; Španěl P J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619 [TBL] [Abstract][Full Text] [Related]
8. Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis. Hanna GB; Boshier PR; Markar SR; Romano A JAMA Oncol; 2019 Jan; 5(1):e182815. PubMed ID: 30128487 [TBL] [Abstract][Full Text] [Related]
9. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Sun X; Shao K; Wang T Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028 [TBL] [Abstract][Full Text] [Related]
10. Mass-Spectrometry Analysis of Mixed-Breath, Isolated-Bronchial-Breath, and Gastric-Endoluminal-Air Volatile Fatty Acids in Esophagogastric Cancer. Adam ME; Fehervari M; Boshier PR; Chin ST; Lin GP; Romano A; Kumar S; Hanna GB Anal Chem; 2019 Mar; 91(5):3740-3746. PubMed ID: 30699297 [TBL] [Abstract][Full Text] [Related]
11. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results. De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489 [TBL] [Abstract][Full Text] [Related]
12. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study. Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848 [TBL] [Abstract][Full Text] [Related]
13. Volatile Markers for Cancer in Exhaled Breath-Could They Be the Signature of the Gut Microbiota? Bhandari MP; Polaka I; Vangravs R; Mezmale L; Veliks V; Kirshners A; Mochalski P; Dias-Neto E; Leja M Molecules; 2023 Apr; 28(8):. PubMed ID: 37110724 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study. Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410 [TBL] [Abstract][Full Text] [Related]
15. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting. Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557 [TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer. van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615 [TBL] [Abstract][Full Text] [Related]
17. Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer. Markar SR; Wiggins T; Antonowicz S; Chin ST; Romano A; Nikolic K; Evans B; Cunningham D; Mughal M; Lagergren J; Hanna GB JAMA Oncol; 2018 Jul; 4(7):970-976. PubMed ID: 29799976 [TBL] [Abstract][Full Text] [Related]
18. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report. Waltman CG; Marcelissen TAT; van Roermund JGH Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583 [TBL] [Abstract][Full Text] [Related]
19. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596 [TBL] [Abstract][Full Text] [Related]
20. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease. van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]